Publisher
Springer Science and Business Media LLC
Reference13 articles.
1. Lowery MA, Klimstra DS, Shia J, et al. Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancy. Oncologist. 2011;16:1714–20.
2. Park W, Chen J, Chou JF, et al. Genomic methods identify homologous recombination deficiency in pancreas adenocarcinoma and optimize treatment selection. Clin Cancer Res. 2020;26:3239–47.
3. La Rosa S, Sessa F, Capella C. Acinar cell carcinoma of the pancreas: overview of clinicopathologic features and insights into the molecular pathology. Front Med (Lausanne). 2015;2:41.
4. Kitagami H, Kondo S, Hirano S, et al. Acinar cell carcinoma of the pancreas clinical analysis of 115 patients from pancreatic cancer registry of Japan Pancreas Society. Pancreas. 2007;35:42–6.
5. Hashimoto M, Hikichi T, Suzuki T, et al. Successful chemotherapy with modified FOLFIRINOX for pancreatic acinar cell carcinoma. Clin J Gastroenterol. 2017;10:564–9.